Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111471121A details a novel two-step synthesis for Sugammadex Sodium dimer impurity, enhancing quality control and reducing analytical risks for global pharmaceutical manufacturers.
Novel patent CN117164568A details solid-state synthesis reducing costs significantly. Enhances supply chain reliability for pharmaceutical intermediates manufacturing globally with high purity.
Novel FeCl3-catalyzed nitro reduction for Relugolix intermediates eliminates palladium residues, ensuring high purity and cost-effective manufacturing for global supply chains.
Patent CN100558905C details a lipase-based resolution for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1254334A discloses novel terephthalamide derivatives inhibiting HBV and HIV. Discover scalable synthesis routes and cost-effective manufacturing strategies for high-purity antiviral intermediates.
Advanced formamide-based refining for high-purity Meropenem. Reduces impurities and boosts yield for scalable API manufacturing.
Patent CN106699730A details a high-yield synthesis route for tetrazole intermediates enabling cost reduction and scalable supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN105461606B details enzymatic hydrolysis for Ledipasvir intermediates. Achieve >99% de value and cost reduction in pharmaceutical intermediate manufacturing.
Advanced enzymatic hydrolysis method for Ledipasvir intermediate CN105461606B. Ensures high purity and supply chain reliability for pharmaceutical manufacturing partners globally.
Novel Ru/C catalyzed hydrogenation and solvent-free isomerization route for high-purity liquid crystal intermediates with over 90% yield.
Patent CN102050800A details a cost-effective chiral resolution method for antidepressant intermediates, replacing complex asymmetric synthesis with scalable salt formation.
Patent CN110790649A details a novel Ni-catalyzed isomerization method for producing high-purity pharmaceutical intermediates with improved cost efficiency and supply chain stability.
Patent CN107778350B details a high-yield solid-phase synthesis for Romidepsin, offering superior purity and cost reduction in pharmaceutical manufacturing.
Patent CN102993142A reveals a high-yield synthesis for 4-hydroxy aurone compounds. Discover cost-effective manufacturing routes and supply chain advantages for pharmaceutical intermediates.
Patent CN114605337B reveals a high-yield bosentan preparation method. This process ensures low impurity content and offers significant supply chain cost advantages.
Patent CN101400647A details an efficient SO3-assisted nitration of isoureas, offering reduced waste acid and higher yields for reliable agrochemical intermediate supply chains.
Patent CN103626782B reveals high-purity synthesis route for opioid antagonist intermediates ensuring supply chain stability and cost efficiency for global pharmaceutical manufacturers seeking reliable partners.
Patent CN105820094A details a novel benzamide compound synthesis for type II diabetes research offering stable properties and scalable manufacturing advantages for global supply chains.
Novel synthesis patent CN107446004A offers cost-effective influenza detection substrate manufacturing with improved purification and supply chain reliability for pharmaceutical intermediates.
Patent CN102209709A details a high-yield route for PDE4 inhibitor intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.